Education

Medical School

• Wright State University School of Medicine

Residency

• Akron City Hospital

Fellowship

• University of Texas S.W. Medical Center

Research & Publications

• Implementing an induction scheduling procedure and consent form to improve quality of care.
  Doyle JL, Kenny TH, von Gruenigen VE, Butz AM, Burkett AM.
  J Obstet Gynecol Neonatal Nurs. 2012 Jul-Aug;41(4):462-73. doi: 10.1111/j.1552-6909.2012.01380.x. Epub 2012 Jun 14.
  
  
• A performance improvement process to tackle tachysystole.
  Doyle J, Kenny TH, Burkett AM, von Gruenigen VE.
  J Obstet Gynecol Neonatal Nurs. 2011 Sep-Oct;40(5):512-9. doi: 10.1111/j.1552-6909.2011.01275.x.
  
  
• The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study.
  von Gruenigen VE, Huang HQ, Gil KM, Frasure HE, Armstrong DK, Wenzel LB.
  Gynecol Oncol. 2012 Mar;124(3):379-82. Epub 2011 Nov 23.
  
  
• A case of chronic paclitaxel administration in ovarian cancer.
  von Gruenigen VE, Karlen JR, Waggoner SE.
  Gynecol Oncol. 2003 Jun;89(3):532-5.
  
  
• Carcinoma of the endometrium.
  von Gruenigen VE, Karlen JR.
  Am Fam Physician. 1995 May 1;51(6):1531-6, 1541-2.
  
  
• Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy.
  von Gruenigen VE, Frasure HE, Kavanagh MB, Lerner E, Waggoner SE, Courneya KS.
  Gynecol Oncol. 2011 Aug;122(2):328-33. Epub 2011 May 19.
  
  
• Toxicity of weekly oral topotecan in relation to dosage for gynecologic malignancies: a phase I study.
  von Gruenigen VE, Frasure HE, Smith DA, Fusco NL, Eaton SM, DeBernardo RL, Heugel AM, Waggoner SE.
  Anticancer Drugs. 2012 Aug;23(7):724-30.
  
  
• Surgical treatments for vulvar and vaginal dysplasia: a randomized controlled trial.
  von Gruenigen VE, Gibbons HE, Gibbins K, Jenison EL, Hopkins MP.
  Obstet Gynecol. 2007 Apr;109(4):942-7.
  
  
• Effect of method of administration on longitudinal assessment of quality of life in gynecologic cancer: an exploratory study.
  Gil KM, Frasure HE, Hopkins MP, Jenison EL, von Gruenigen VE.
  Health Qual Life Outcomes. 2005 Jan 17;3:6.
  
  
• Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study.
  von Gruenigen VE, Tian C, Frasure H, Waggoner S, Keys H, Barakat RR.
  Cancer. 2006 Dec 15;107(12):2786-91.
  
  
• A comparison of quality-of-life domains and clinical factors in ovarian cancer patients: a Gynecologic Oncology Group study.
  von Gruenigen VE, Huang HQ, Gil KM, Gibbons HE, Monk BJ, Rose PG, Armstrong DK, Cella D, Wenzel L.
  J Pain Symptom Manage. 2010 May;39(5):839-46.
  
  
• Bariatric surgery in the field of gynecological oncology.
  Green AE, Escobar PF, Stellato T, Hallowell P, von Gruenigen VE.
  Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1254-7.
  
  
• Abdominal compartment syndrome in gynecologic surgery.
  von Gruenigen VE, Coleman RL, King MR, Miller DS.
  Obstet Gynecol. 1999 Nov;94(5 Pt 2):830-2.
  
  
• Physical activity and gynecologic cancer survivorship.
  Gil KM, von Gruenigen VE.
  Recent Results Cancer Res. 2011;186:305-15. Review.
  
  
• Futility: clinical decisions at the end-of-life in women with ovarian cancer.
  von Gruenigen VE, Daly BJ.
  Gynecol Oncol. 2005 May;97(2):638-44. Review.
  
  
• Gynecologic oncology patients' satisfaction and symptom severity during palliative chemotherapy.
  von Gruenigen VE, Hutchins JR, Reidy AM, Gibbons HE, Daly BJ, Eldermire EM, Fusco NL.
  Health Qual Life Outcomes. 2006 Oct 30;4:84.
  
  
• Treating ovarian cancer patients at the end of life: when should we stop?
  von Gruenigen VE, Daly BJ.
  Gynecol Oncol. 2005 Nov;99(2):255-6. Epub 2005 Sep 29. No abstract available.
  
  
• Women's cancer survivorship: time to gear up!
  Bodurka DC, von Gruenigen VE.
  Gynecol Oncol. 2012 Mar;124(3):377-8. No abstract available.
  
  
• Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials.
  von Gruenigen VE, Huang HQ, Gil KM, Gibbons HE, Monk BJ, Rose PG, Armstrong DK, Cella D, Wenzel L.
  Cancer. 2009 Oct 15;115(20):4857-64.
  
  
• Health care reform: will quality remodeling affect obstetrician-gynecologists in addition to patients?
  von Gruenigen VE, Deveny TC.
  Obstet Gynecol. 2011 May;117(5):1167-9.

For more publications by Vivian von Gruenigen, M.D., please visit PubMed.

Professional Highlights

Vivian von Gruenigen, M.D., is the author of more than 100 journal articles and abstracts and is an editorial board member at Gynecologic Oncology. Dr. von Gruenigen is a board member at Gynecologic Cancer Foundation, American Board of Obstetrics and Gynecology’s Exxcellence Foundation and Summa Health System’s Accountable Care Organization. She is a dual board examiner for the American Board of Obstetrics and Gynecology. She also is the principal investigator (PI) for two active NCI funded Gynecologic Oncology Group clinical trials, which focus on unmet needs in women with ovarian cancer. Dr. von Gruenigen is also the Summa Foundation’s endowed chair in women’s health. Prior to her position at Summa Health System, Dr. von Gruenigen was director of robotic surgery at University Hospitals Case Medical Center in Cleveland, Ohio.

Awards and Honors

Vivian von Gruenigen, M.D., has received numerous teaching and research awards from multiple institutions. Dr. von Gruenigen has been named one of the “Best Doctors in America” by the Consumer’s Research Council of America as well as one of “America’s Top Oncologists” by Cleveland Magazine. She was honored by the Athena International Leadership organization in 2011 and 2012. In 2012 she was awarded Outstanding Alumni Award for Wright State University, Boonshoft School of Medicine. Also in 2012, she received the 1st Annual Richard Ireland Award at the World Congress Leadership Summit on the Business of Women’s Health.

Patient Forms